Moneycontrol PRO

82% workforce prefers returning to offices after vaccination: Report

As many as 72 percent favours the hybrid work model.

72 percent of workforce favour a hybrid work model that is a combination of working from home and working from the office premises.

72 percent of workforce favour a hybrid work model that is a combination of working from home and working from the office premises.

As many as 82 percent workforce prefers returning to office premises with some level of flexibility once they are vaccinated and 72 percent favour a hybrid work model that is a combination of working from home and working from the office premises, a new report by Awfis, a network of co-working spaces, has said.

Awfis Workspace Survey Report offers a comprehensive assessment of how India’s work ecosystem has transformed following the second wave of COVID-19.

It said that 71 percent of the respondents find managing teams easier in offices, 72 percent are satisfied with networking in a physical workspace thus highlighting that, physical offices will continue to be the key for collaboration, culture, and overall business success.

As many as 74 percent of the participants admitted to being unsatisfied as far as career advancement is concerned, with many experiencing diminished professional growth due to continued remote work.

Almost 57 percent of the workforce is ready to trade in a higher salary to do part-remote work or consider leaving the company for another job that offers them more flexible options. Another 58 percent desired the flexibility to work from the nearest branch office or co-working space, the report said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
As many as 1,000 Indian working professionals across different job roles and industries participated in the survey. The survey was undertaken in May and June 2021 and covers participants from seven metros.
Moneycontrol News
first published: Jul 1, 2021 05:07 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark